Levetiracetam Tablet, Film Coated
Product Images NDC 63629-4675

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 63629-4675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 01

A formula depicting how to calculate total daily dose (mL/day) of a medication based on daily dose (mg/kg/day) multiplied by patient weight (kg), divided by concentration of 100 mg/mL. The text is part of dosing instructions or guidance.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 02

A text excerpt showing formulas for calculating creatinine clearance (CLcr) based on age, weight, serum creatinine, and body surface area (BSA), with an adjustment factor for female patients. The calculation guidelines detail how to adjust CLcr for individual patient BSA.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 03

Chemical structure of levetiracetam shown as a skeletal formula with a pyrrolidone ring and side chains including an ethyl group and an amide functional group.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 04

A bar graph comparing the percentage of patients across three groups: Placebo (7.4%, N=95), Levetiracetam 1000 mg/day (37.1%, N=97), and Levetiracetam 3000 mg/day (39.6%, N=101). The y-axis represents the percentage of patients from 0% to 45%, showing higher percentages in the Levetiracetam groups compared to placebo.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 05

A bar chart comparing the percentage of patients across three groups: placebo (6.3%, N=111), Levetiracetam 1000 mg/day (20.8%, N=106), and Levetiracetam 2000 mg/day (35.2%). The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 06

A bar chart comparing the percentage of patients reporting an outcome for two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The y-axis represents the percentage of patients, with the Levetiracetam group showing a higher percentage around 39.4% compared to the Placebo group at 14.4%.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 07

A bar chart comparing the percentage of patients in two groups: placebo (N=97) and Levetiracetam (N=101). The y-axis represents the percentage of patients, with the placebo group at 19.6% and the Levetiracetam group at 44.6%. An asterisk marks the Levetiracetam bar.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 08

A bar graph comparing the percentage of patients between two groups: Placebo (N=51) with 19.6% and Levetiracetam (N=58) with 43.1%. The y-axis represents the percentage of patients, ranging from 0% to 45%. The graph visually highlights a higher percentage for the Levetiracetam group.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 09

Bar chart comparing the percentage of patients between placebo group (45.2%, N=84) and Levetiracetam group (72.2%, N=79). The y-axis represents % of patients from 0% to 100%. The chart highlights a higher percentage for Levetiracetam with an asterisk above the bar.*

FDA Label Image

Lbl636294675

Levetiracetam 250 mg film-coated tablet label from Bryant Ranch Prepack, with a package size of 60 tablets. The label compares this product to Keppra 250 mg tablets by Lupin Limited. It includes storage instructions at 20-25°C (68-77°F), a warning to keep drugs out of the reach of children, and the NDC 63629-4675. The label features a barcode and lot number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.